Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1633 1647 1653 1655
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18409304 | METHODS AND COMPOSITIONS FOR GENE TRANSFER ACROSS THE VASCULATURE | Non-Final OA | The University of North Carolina at Chapel Hill |
| 17996966 | NOVEL T-CELL SPECIFICITIES AND USES THEREOF | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18484777 | METHODS AND COMPOSITIONS FOR THE TARGETED MODIFICATION OF A GENOME | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18115321 | CELL CULTURE METHODS FOR ANTIBODY PRODUCTION | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18371302 | METHODS FOR TRANSDUCTION AND CELL PROCESSING | Non-Final OA | Juno Therapeutics, Inc. |
| 18148886 | TARGETING BCL11A ENHANCER FUNCTIONAL REGIONS FOR FETAL HEMOGLOBIN REINDUCTION | Non-Final OA | Massachusetts Institute of Technology |
| 17618774 | RECOMBINANT AD35 VECTORS AND RELATED GENE THERAPY IMPROVEMENTS | Final Rejection | University of Washington |
| 18519972 | METHODS AND COMPOSITIONS FOR TREATING METASTATIC BREAST CANCER AND OTHER CANCERS IN THE BRAIN | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18358808 | MID-SCALE VESSELS IN ENGINEERED TISSUE FOR REGENERATION | Non-Final OA | Brown University |
| 18069650 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALS | Final Rejection | University of Cincinnati |
| 18507432 | NEUROPROTECTIVE MOLECULES AND METHODS OF TREATING NEUROLOGICAL DISORDERS AND INDUCING STRESS GRANULES | Non-Final OA | The Brigham and Women's Hospital, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy